Sunesis Pharmaceutical ... handle with care!
Sunesis is a biopharmaceutical company engaged in the development and commercialization of new cancer therapies for the treatment of solid tumors and hematological.
Sunesis has built a great development experience in the fight against cancer.
L 'organization committed to promoting the vosaroxin in multiple indications to improve the lives of cancer patients through the development and commercialization of drugs for the treatment of cancer.
The title has a market capitalization of 129.04 mln. $.
the title after a long period of sales is catching up to 200 times the average.
In the week before Christmas he traveled on a roller coaster, alternating growth of 25% to 10% drop in just two days.
On December 23 ended the session with a +11.36% to $ 0.49, with volumes increasing.
As a pharmaceutical and 'to treat with the springs as these securities are often the result of real estate speculation, but if treated with due caution or a' minimum investment could also give satisfaction.
One thing I notice is 'the attack on the media just made a' year ago.
Increased volumes, double-digit percentages. From
noted the gaps left open for $ 0.39.
Personally I groped for a real challenge for this title.
I repeat that it is a pharmaceutical and 'undoubtedly a security deposit account in style ... so ..
Treat it with the tongs!
Greetings to all wherever you are!
0 comments:
Post a Comment